Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Other Working Capital Changes (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Other Working Capital Changes for 2 consecutive years, with -$678446.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 844.14% to -$678446.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$188873.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $453058.0 for FY2025, 3886.84% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$678446.0 at Neuphoria Therapeutics, down from -$34793.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $654861.0 in Q2 2025, with the low at -$678446.0 in Q4 2025.